Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma

NCT02291848 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

BIOLOGICAL: TAA-specific CTLs
BIOLOGICAL: TAA-specific CTLs- fixed dose

Sponsor

Baylor College of Medicine

Collaborators

[object Object]
[object Object]
[object Object]